Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms

Claudia Avella-García, Jordi Júlvez, Joan Fortuny, +9

International Journal of Epidemiology

Maternal use of folic acid supplements during pregnancy and four‐year‐old neurodevelopment in a population‐based birth cohort

Jordi Júlvez, Joan Fortuny, Michelle A. Méndez, +3

Paediatric and Perinatal Epidemiology

NutritionMaternal UseFolic Acid SupplementsBrain DevelopmentHigh-risk Pregnancy +21

Risk of Endometrial Cancer in Relation to Medical Conditions and Medication Use

Joan Fortuny, Camelia S. Sima, Sharon Bayuga, +5

Cancer Epidemiology Biomarkers & Prevention

Hormonal ContraceptiveEpidemiology Of CancerReproductive HealthGynecologyMenstrual Cycle +18

Statin Use and Risk of Lymphoid Neoplasms: Results from the European Case-Control Study EPILYMPH

Joan Fortuny, Sílvia de Sanjosé, Nikolaus Becker, +9

Cancer Epidemiology Biomarkers & Prevention

Glucocorticoid therapy and risk of bladder cancer

K. Dietrich, Alan R. Schned, Joan Fortuny, +4

British Journal of Cancer

Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom

Andrea V. Margulis, Joan Fortuny, James A. Kaye, +9

Epidemiology

Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter–Relaxing Drugs and Risk of Esophageal and Gastric Cancers

Joan Fortuny, Christine Cole Johnson, Kari Bohlke, +8

Clinical Gastroenterology and Hepatology

InflammationOncologyAnti-inflammatory AgentsEsophagusEsophageal Cancer +9

Tobacco, occupation and non-transitional-cell carcinoma of the bladder: An international case-control study

Joan Fortuny, Manolis Kogevinas, Jenny Chang‐Claude, +11

International Journal of Cancer

Epidemiology Of CancerPathologyCancer Risk FactorsCarcinomaTobacco Control +15

Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study

Joan Fortuny, Manolis Kogevinas, Michael S. Zens, +5

BMC Urology

Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain

Joan Fortuny, Manolis Kogevinas, Montserrat García‐Closas, +11

Cancer Epidemiology Biomarkers & Prevention